On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Magle Biopharma AB's own share of each project, not the project's full budget.
- Horizon Europe€586k · 1 project
Projects
1 EU-funded project, newest first. Magle Biopharma AB led 1 of them as coordinator. Each links to the official record.
- HyperTargIPS-NKCoordinator
Hyper-targeting CAR NK cells from induced pluripotent stem cells for novel off-the-shelf anti-tumor therapies
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€586ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
Fields it works in
Research fields recorded on its Horizon projects.
- leukemia
- transplantation
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.